A trading opportunity for you?

Will Indivior continue falling, or will it rise again back to 277p September highs?

• The price has fallen over 26.2% in one week. Shares are now at 2-year lows.
• Shares are down over 57.3% down from 2018 highs, -51% year-to-date.
• Company warned that it expects lower FY revenue ($230-255m) and reduced sales guidance for its Sublocade opioid treatment.
• Indivior underestimated the lag time associated with drug approval for individual patients.
• Brokers are projecting even lower $225m revenue estimate.
• Shares have been as high as 277p in September, and as low as 196p. It is now at 200p.
• Will the sell-off continue, or can the shares recover?

Click to enlarge

Trading Indivior – An Example

Let’s say you feel that the stock is a bargain and you think could bounce back towards September high of 277p. You decide to buy exposure to £10,000 worth of Indivior using a CFD, at the current price of 200p. To do this, you need £2,000.

Let’s assume Indivior recovers back to 277p (+38.5%). Your profit would be £3,850, from your initial investment of £2,000.

Conversely, let’s assume you open the above position, and place a stop-loss at 10% from the current price. Indivior falls 10% and hits your stop-loss. Your loss would be £1,000.

This is provided for information purposes only. It should not be taken as a recommendation.